CHANGES IN OVERACTIVE BLADDER SYMPTOMS AFTER DISCONTINUATION OF SUCCESSFUL 3-MONTH TREATMENT WITH AN ANTIMUSCARINIC AGENT: A PROSPECTIVE TRIAL

Of patients 35% sought re-treatment 1 month after the discontinuation of antimuscarinic therapy. Patients older than 55 years or those with severe urgency may more frequently receive re-treatment and patients with DO may experience more rapid symptom recurrence after medication discontinuation.